KCT0008025Not yet recruiting
Untitled Trial
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer and the companion diagnostic development
National Cancer CenterPhase 1/2Korean Clinical Trial Registry
VerifiedKorean Clinical Trial Registry
Study focus
- Disease/Condition
- gastric cancer
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- National Cancer Center
- Location
- South Korea
Timeline & enrollment
- Phase
- Phase 1/2
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- Korean Clinical Trial Registry
- Trial ID
- KCT0008025
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for KCT0008025 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by National Cancer Center and is currently Not yet recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Korean Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.